Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Tuberculosis Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Pfizer
Sanofi
Otsuka Novel Products
By Type:
Second-line Anti-TB Drugs
First-line Anti-TB Drugs
By Application:
Active TB
Latent TB
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Tuberculosis Drug Market Overview 2018-2029
-
1.1 China Tuberculosis Drug Industry Development Overview
-
1.2 China Tuberculosis Drug Industry Development History
-
1.3 China Tuberculosis Drug Industry Market Size (2018-2029)
-
1.4 China Tuberculosis Drug Market Analysis by Type from Production Side
-
1.4.1 China Tuberculosis Drug Production Volume, Production Value and Growth Rate of Second-line Anti-TB Drugs (2018-2029)
-
1.4.2 China Tuberculosis Drug Production Volume, Production Value and Growth Rate of First-line Anti-TB Drugs (2018-2029)
-
1.5 China Tuberculosis Drug Market Analysis by Application from Consumption End
-
1.5.1 China Tuberculosis Drug Sales Volume, Sales Value and Growth Rate of Active TB (2018-2029)
-
1.5.2 China Tuberculosis Drug Sales Volume, Sales Value and Growth Rate of Latent TB (2018-2029)
-
1.6 China Tuberculosis Drug Market Analysis by Region
-
1.6.1 North China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Tuberculosis Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Tuberculosis Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Tuberculosis Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Tuberculosis Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Tuberculosis Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Tuberculosis Drug Industry Development
Chapter 3 Tuberculosis DrugIndustry Chain Analysis
-
3.1 Tuberculosis Drug Industry Chain
-
3.2 Tuberculosis Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Tuberculosis Drug Market
-
3.3 Tuberculosis Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Tuberculosis Drug Market
Chapter 4 China Tuberculosis Drug Market, by Type
-
4.1 China Tuberculosis Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Tuberculosis Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Tuberculosis Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Tuberculosis Drug Production Volume and Growth Rate of Second-line Anti-TB Drugs
-
4.5.2 China Tuberculosis Drug Production Volume and Growth Rate of First-line Anti-TB Drugs
Chapter 5 China Tuberculosis Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Tuberculosis Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Tuberculosis Drug Market Size and Growth Rate, by Application
-
5.5.1 China Tuberculosis Drug Market Size and Growth Rate of Active TB
-
5.5.2 China Tuberculosis Drug Market Size and Growth Rate of Latent TB
Chapter 6 China Tuberculosis Drug Market, by Region
-
6.1 China Tuberculosis Drug Production Volume and Production Value, by Region
-
6.2 China Tuberculosis Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Tuberculosis Drug Market Analysis
-
7.1 North China Tuberculosis Drug Market, by Type
-
7.2 North China Tuberculosis Drug Market, by Application
Chapter 8 Central China Tuberculosis Drug Market Analysis
-
8.1 Central China Tuberculosis Drug Market, by Type
-
8.2 Central China Tuberculosis Drug Market, by Application
Chapter 9 South China Tuberculosis Drug Market Analysis
-
9.1 South China Tuberculosis Drug Market, by Type
-
9.2 South China Tuberculosis Drug Market, by Application
Chapter 10 East China Tuberculosis Drug Market Analysis
-
10.1 East China Tuberculosis Drug Market, by Type
-
10.2 East China Tuberculosis Drug Market, by Application
Chapter 11 Northeast China Tuberculosis Drug Market Analysis
-
11.1 Northeast China Tuberculosis Drug Market, by Type
-
11.2 Northeast China Tuberculosis Drug Market, by Application
Chapter 12 Southwest China Tuberculosis Drug Market Analysis
-
12.1 Southwest China Tuberculosis Drug Market, by Type
-
12.2 Southwest China Tuberculosis Drug Market, by Application
Chapter 13 Northwest China Tuberculosis Drug Market Analysis
-
13.1 Northwest China Tuberculosis Drug Market, by Type
-
13.2 Northwest China Tuberculosis Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Pfizer
-
14.1.1 Pfizer Company Profile
-
14.1.2 Pfizer Tuberculosis Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Sanofi
-
14.2.1 Sanofi Company Profile
-
14.2.2 Sanofi Tuberculosis Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Otsuka Novel Products
-
14.3.1 Otsuka Novel Products Company Profile
-
14.3.2 Otsuka Novel Products Tuberculosis Drug Market Performance
-
14.3.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Tuberculosis Drug Industry Research Conclusions
-
15.2 Tuberculosis Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Tuberculosis Drug Industry Market Size (2018-2029)
-
Figure China Tuberculosis Drug Production Volume, Production Value and Growth Rate of Second-line Anti-TB Drugs (2018-2029)
-
Figure China Tuberculosis Drug Production Volume, Production Value and Growth Rate of First-line Anti-TB Drugs (2018-2029)
-
Figure China Tuberculosis Drug Sales Volume, Sales Value and Growth Rate of Active TB (2018-2029)
-
Figure China Tuberculosis Drug Sales Volume, Sales Value and Growth Rate of Latent TB (2018-2029)
-
Figure North China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Tuberculosis Drug Market Size and Growth Rate from 2018-2029
-
Figure Tuberculosis Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Tuberculosis Drug Market Share by Type in 2018
-
Figure China Tuberculosis Drug Market Share by Type in 2023
-
Figure China Tuberculosis Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Tuberculosis Drug Production Volume and Growth Rate of Second-line Anti-TB Drugs (2018-2023)
-
Figure China Tuberculosis Drug Production Volume and Growth Rate of First-line Anti-TB Drugs (2018-2023)
-
Figure China Tuberculosis Drug Market Share by Application in 2018
-
Figure China Tuberculosis Drug Market Share by Application in 2023
-
Figure China Tuberculosis Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Tuberculosis Drug Market Size and Growth Rate of Active TB (2018-2023)
-
Figure China Tuberculosis Drug Market Size and Growth Rate of Latent TB (2018-2023)
-
Table China Tuberculosis Drug Production Volume by Region (2018-2023)
-
Table China Tuberculosis Drug Production Volume Share by Region (2018-2023)
-
Figure China Tuberculosis Drug Production Volume Share by Region (2018-2023)
-
Table China Tuberculosis Drug Production Value by Region (2018-2023)
-
Table China Tuberculosis Drug Production Value Share by Region (2018-2023)
-
Figure China Tuberculosis Drug Production Value Share by Region (2018-2023)
-
Table China Tuberculosis Drug Sales Volume by Region (2018-2023)
-
Table China Tuberculosis Drug Sales Volume Share by Region (2018-2023)
-
Figure China Tuberculosis Drug Sales Volume Share by Region (2018-2023)
-
Table China Tuberculosis Drug Sales Value by Region (2018-2023)
-
Table China Tuberculosis Drug Sales Value Share by Region (2018-2023)
-
Figure China Tuberculosis Drug Sales Value Share by Region (2018-2023)
-
Table North China Tuberculosis Drug Production Volume by Type (2018-2023)
-
Table North China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Figure North China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Table North China Tuberculosis Drug Sales Volume by Application (2018-2023)
-
Table North China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Tuberculosis Drug Production Volume by Type (2018-2023)
-
Table Central China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Table Central China Tuberculosis Drug Sales Volume by Application (2018-2023)
-
Table Central China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Table South China Tuberculosis Drug Production Volume by Type (2018-2023)
-
Table South China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Figure South China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Table South China Tuberculosis Drug Sales Volume by Application (2018-2023)
-
Table South China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Table East China Tuberculosis Drug Production Volume by Type (2018-2023)
-
Table East China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Figure East China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Table East China Tuberculosis Drug Sales Volume by Application (2018-2023)
-
Table East China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Tuberculosis Drug Production Volume by Type (2018-2023)
-
Table Northeast China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Tuberculosis Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Tuberculosis Drug Production Volume by Type (2018-2023)
-
Table Southwest China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Tuberculosis Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Tuberculosis Drug Production Volume by Type (2018-2023)
-
Table Northwest China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Tuberculosis Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Tuberculosis Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Tuberculosis Drug Sales Volume Share by Application (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Tuberculosis Drug Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Tuberculosis Drug Revenue, Price and Gross (2018-2023)
-
Table Otsuka Novel Products Company Profile
-
Table Otsuka Novel Products Tuberculosis Drug Revenue, Price and Gross (2018-2023)
-
